Letter from the HBA Metro Chapter President

Summary: 

Stephanie Bova is the 2011 president of the Healthcare Businesswomen’s Association She has been in the HBA since 2003 and credits the HBA with providing exemplary opportunities for building key relationships and leadership skills.

By Stephanie Bova, Pfizer Inc

I have discovered great value and far-reaching benefits from being a member of the HBA for the last eight years, The HBA has provided ample opportunity for me to develop leadership skills in ways that I would not have been able to do otherwise. One of my favorite quotes, by Adele Gulfo, president of primary care at Pfizer, illustrates the importance of leadership to me. It is, “People don’t follow strategy, people follow people.”

I have observed different types of leaders, from natural-born leaders, who exude energy and excitement and to whom people gravitate, to developed leaders who have attained phenomenal leadership skills through training. To me, being a leader is always doing the right thing and making the right professional and personal decisions for people and myself. Ask yourself, “What kind of leader do I want to be?” Is it being the best you can be for yourself, developing or fine-tuning your skills? Is it being great at leading others, and what exactly does that mean to you? The HBA can help you figure out the kind of leader you want to be and then provide you with resources and opportunities to become that leader.

Over the years, I have also learned several ways to gain the best possible value out of the HBA. Through the HBA I have access to people and opportunities that I would not necessarily have access to in my day job. By participating in HBA activities and programs, I have built a solid external network that has been there in times of crisis, offering advice and career insights. With the HBA, I have been able to explore potential opportunities, learning that the grass is not always greener on the other side, before going to the other side.

The greatest value I have gained from the HBA is from the benefits of volunteering. Volunteering enhances the value gained from networking by elevating the transactional, business card exchange to a more substantive interaction and potential relationship. Volunteering affords a reason to connect with others for a common goal, to create change for the better, and to help women advance in healthcare. Never underestimate the power of networking and boosting that power by volunteering.

HBA runs on the fuel of volunteers, and this is HBA’s year of the volunteer. Take this opportunity to get involved and pay it forward. Helping others is the best way to improve yourself and gain valuable opportunities. Those who contribute by volunteering never go unnoticed. Helping other women advance their careers will cause a positive ripple effect in all aspects of your life. By staying involved, I have had the great fortune of meeting many inspiring women, and to watch the next generation of women leaders being created. So take the time to contribute to the HBA by volunteering and reap the rewards!

Stephanie BovaStephanie Bova, 2011 President, HBA Metro Chapter

Stephanie Bova is the 2011 president of the Healthcare Businesswomen’s Association She has been in the HBA since 2003 and credits the HBA with providing exemplary opportunities for building key relationships and leadership skills.

Stephanie is the global brand lead for Spiriva at Pfizer Inc responsible for brand stewardship and alliance governance for marketing. She joined Pfizer in 2006 as a member of the Lipitor global marketing team before being promoted to director of Japan/Korea for Primary Care Business Unit.

Before joining Pfizer, Stephanie spent 2 years at Altana Pharma where she was responsible for the development and commercialization of ciclesonide, a corticosteroid that had multiple formulations, which was being co-developed with sanofi-aventis. Stephanie also spent over seven years in Tokyo, Japan, mostly in the field of life science strategy consulting, where she worked with a variety of global biopharmaceutical companies.

News Categories: 
Groups audience: